Ionis Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 05/12/2025 | 23.61 M | $712.42 M | 4.07% | 14.88% |
VANGUARD GROUP INC | 05/09/2025 | 16.38 M | $494.30 M | -0.54% | 10.32% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 16.18 M | $488.02 M | 14.16% | 10.19% |
CAPITAL WORLD INVESTORS | 05/12/2025 | 12.36 M | $372.96 M | 7.82% | 7.79% |
BLACKROCK, INC. | 05/02/2025 | 11.26 M | $339.85 M | -3.44% | 7.10% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 8.42 M | $253.92 M | -2.95% | 5.30% |
BELLEVUE GROUP AG | 05/14/2025 | 7.85 M | $236.93 M | -0.20% | 4.95% |
STATE STREET CORP | 05/15/2025 | 4.85 M | $146.18 M | -10.71% | 3.05% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 4.56 M | $137.70 M | 136.01% | 2.88% |
CITADEL ADVISORS LLC | 05/15/2025 | 3.48 M | $104.99 M | 60.67% | 2.19% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 3.27 M | $98.51 M | -14.68% | 2.06% |
TWEEDY, BROWNE CO LLC | 05/15/2025 | 2.98 M | $90.01 M | -8.17% | 1.88% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.84 M | $85.80 M | 5.79% | 1.79% |
ORBIMED ADVISORS LLC | 05/15/2025 | 2.54 M | $76.64 M | -9.84% | 1.60% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 2.09 M | $63.12 M | 55.05% | 1.32% |
BVF INC/IL | 05/15/2025 | 1.91 M | $57.73 M | 100.00% | 1.21% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 1.69 M | $50.86 M | 82.96% | 1.06% |
MACQUARIE GROUP LTD | 05/15/2025 | 1.67 M | $50.30 M | -5.79% | 1.05% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.44 M | $43.55 M | -2.55% | 0.91% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 1.20 M | $36.10 M | 10.74% | 0.75% |
MORGAN STANLEY | 05/15/2025 | 1.14 M | $34.52 M | -13.97% | 0.72% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 1.10 M | $33.20 M | 4.81% | 0.69% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.08 M | $32.45 M | 291.13% | 0.68% |
GROUPAMA ASSET MANAGMENT | 05/14/2025 | 1.07 M | $18.23 M | 5.11% | 0.67% |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 1.05 M | $31.68 M | 27.85% | 0.66% |
ARK INVESTMENT MANAGEMENT LLC | 05/07/2025 | 1.00 M | $30.19 M | -2.41% | 0.63% |
CANDRIAM S.C.A. | 05/14/2025 | 993.70 K | $29.98 M | 16.93% | 0.63% |
INVESCO LTD. | 05/12/2025 | 874.83 K | $26.39 M | 10.94% | 0.55% |
NORTHERN TRUST CORP | 05/13/2025 | 834.85 K | $25.19 M | -0.65% | 0.53% |
BANK OF MONTREAL /CAN/ | 05/13/2025 | 782.84 K | $23.62 M | 150.79% | 0.49% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 767.43 K | $23.15 M | 81.49% | 0.48% |
CAMBER CAPITAL MANAGEMENT LP | 05/15/2025 | 725.00 K | $21.87 M | 16.00% | 0.46% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 659.44 K | $19.90 M | 6.42% | 0.42% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 652.52 K | $19.69 M | 72.53% | 0.41% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 635.37 K | $19.17 M | -17.93% | 0.40% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 618.55 K | $19.25 M | -0.36% | 0.39% |
ROYAL BANK OF CANADA | 05/15/2025 | 616.08 K | $18.59 M | -4.22% | 0.39% |
PINNACLE ASSOCIATES LTD | 05/06/2025 | 608.52 K | $18.36 M | 11.12% | 0.38% |
AXA S.A. | 05/15/2025 | 566.49 K | $17.09 M | -6.42% | 0.36% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 560.36 K | $16.91 M | 50.89% | 0.35% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 544.63 K | $16.43 M | -11.60% | 0.34% |
EVERSEPT PARTNERS, LP | 05/15/2025 | 517.02 K | $15.60 M | 140.53% | 0.33% |
TEACHER RETIREMENT SYSTEM OF TEXAS | 04/28/2025 | 500.45 K | $15.10 M | 660.66% | 0.32% |
ABRDN PLC | 05/13/2025 | 446.20 K | $13.50 M | 11.13% | 0.28% |
CITIGROUP INC | 05/12/2025 | 426.48 K | $12.87 M | 152.12% | 0.27% |
JPMORGAN CHASE & CO | 05/12/2025 | 421.51 K | $12.72 M | 1.34% | 0.27% |
C WORLDWIDE GROUP HOLDING A/S | 05/05/2025 | 400.00 K | $12.07 M | 0.00% | 0.25% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 377.20 K | $11.38 M | 19.01% | 0.24% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 360.19 K | $10.87 M | -7.04% | 0.23% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 357.92 K | $10.80 M | 0.00% | 0.23% |
Ionis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 516 institutional investors and hedge funds held shares of Ionis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FMR LLC: 23.61 M
VANGUARD GROUP INC: 16.38 M
T. Rowe Price Investment Management, Inc.: 16.18 M
Capital World Investors: 12.36 M
BlackRock, Inc.: 11.26 M
WELLINGTON MANAGEMENT GROUP LLP: 8.42 M
104.79% of Ionis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 201.15 M shares in the last 24 months. This purchase volume represents approximately $6.74 B in transactions.